Basilea Pharmaceutica AG/ CH0011432447 /
| 2024-08-02 5:19:56 PM | Chg. -1.25 | Volume | Bid5:20:00 PM | Ask5:20:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 38.80CHF | -3.12% | 2,104 Turnover: 81,303.08 |
-Bid Size: - | -Ask Size: - | 504.34 mill.CHF | - | 44.25 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.87 CHF | -14.71% |
| EPS Diluted: | - CHF | -15.69% |
| Revenues per Share: | 12.03 CHF | 6.65% |
| Book Value per Share: | -0.76 CHF | -51.73% |
| Cash Flow per Share: | 1.09 CHF | 101.72% |
| Dividend per Share: | - CHF | - |
| Total | in mill. | |
| Revenues: | 157.63 CHF | 6.68% |
| Net Income: | 10.45 CHF | -13.98% |
| Operating Cash Flow: | 14.25 CHF | - |
| Cash and Cash Equivalents: | 59.93 CHF | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 44.25 | 40.57 |
| P/S Ratio: | 3.20 | 2.93 |
| P/BV ratio: | -50.42 | -46.23 |
| P/CF Ratio: | 35.40 | 32.46 |
| PEG: | -3.01 | -2.76 |
| Earnings Yield: | 2.26% | 2.46% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 504.34 mill. CHF | 462.42 mill. CHF |
| Free Float Market Cap.: | - CHF | - CHF |
| Market Cap. / Employee: | 3.43 mill. CHF | 3.15 mill. CHF |
| Shares Outstanding: | 13.1 mill. | |
Profitability
| Gross Profit Margin: | 83.00% |
| EBIT Margin: | 12.18% |
| Net Profit Margin: | 6.63% |
| Return on Equity: | - |
| Return on Assets: | 6.03% |
Financial Strength
| Liquidity I / Cash Ratio: | 125.93% |
| Liquidity II / Quick Ratio: | 184.54% |
| Liquidity III / Current Ratio: | 319.69% |
| Debt / Equity Ratio: | - |
| Dynam. Debt / Equity Ratio: | 1,286.71% |
Efficiency
| Employees: | 147 |
| Personal Expenses / Employee: | - CHF |
| Revenues / Employee: | 1,072,340.14 CHF |
| Net Income / Employee: | 71,095.24 CHF |
| Total Assets / Employee: | 1,178,836.73 CHF |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | CHF |
